ACADIA Pharmaceuticals
ACAD
#3219
Rank
S$5.87 B
Marketcap
S$34.71
Share price
-0.30%
Change (1 day)
39.68%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): S$0.36 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are S$1.04 Billion. In 2024 the company made an earning of S$0.33 Billion, an increase over its 2023 earnings that were of -S$66.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.36 B9.2%
2024 S$0.33 B-605.67%
2023 -S$66.09 Million-76.09%
2022 -S$0.28 Billion27.41%
2021 -S$0.22 Billion-40.38%
2020 -S$0.37 Billion19.88%
2019 -S$0.31 Billion-3.92%
2018 -S$0.32 Billion-15.04%
2017 -S$0.38 Billion6.33%
2016 -S$0.35 Billion64.55%
2015 -S$0.22 Billion77.47%
2014 -S$0.12 Billion143.69%
2013 -S$49.14 Million81.93%
2012 -S$27.01 Million-8.73%
2011 -S$29.59 Million-251.39%
2010 S$19.54 M-133.2%
2009 -S$58.88 Million-30.82%
2008 -S$85.11 Million6.43%
2007 -S$79.97 Million25.89%
2006 -S$63.52 Million36.99%
2005 -S$46.37 Million37.22%
2004 -S$33.79 Million19.96%
2003 -S$28.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-S$0.16 Billion-144.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.34 B 4,230.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.13 B 8,122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.94 B 11,737.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.40 B 2,835.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-S$50.02 Million-114.12%๐Ÿ‡บ๐Ÿ‡ธ USA